UCB, Oxford Instruments Molecular Biotools Ltd., University of Durham deal

Under a two-year deal, the parties will develop an antibody-targeted magnetotherapy technology to treat cancer. UCB's Celltech Group plc unit will contribute its targeted antibody technology. Scienti...